These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31140861)

  • 81. Anticancer Ir
    Wu XW; Zheng Y; Wang FX; Cao JJ; Zhang H; Zhang DY; Tan CP; Ji LN; Mao ZW
    Chemistry; 2019 May; 25(28):7012-7022. PubMed ID: 30913329
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Metallo-organic G-quadruplex ligands in anticancer drug design.
    Jiang YL; Liu ZP
    Mini Rev Med Chem; 2010 Jul; 10(8):726-36. PubMed ID: 20412042
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities.
    Fei BL; Tu S; Wei Z; Wang P; Qiao C; Chen ZF
    Eur J Med Chem; 2019 Aug; 176():175-186. PubMed ID: 31103898
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Advances in cobalt complexes as anticancer agents.
    Munteanu CR; Suntharalingam K
    Dalton Trans; 2015 Aug; 44(31):13796-808. PubMed ID: 26148776
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Technologies to develop new metal medicines.
    Dufrasne F
    Drug Discov Today Technol; 2015 Sep; 16():31-2. PubMed ID: 26547419
    [No Abstract]   [Full Text] [Related]  

  • 86. Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
    Hartinger CG
    Angew Chem Int Ed Engl; 2010 Nov; 49(45):8304-5. PubMed ID: 20803595
    [No Abstract]   [Full Text] [Related]  

  • 87. Strained ruthenium complexes are potent light-activated anticancer agents.
    Howerton BS; Heidary DK; Glazer EC
    J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The use of Resonant X-ray Emission Spectroscopy (RXES) for the electronic analysis of metal complexes and their interactions with biomolecules.
    Sá J; Czapla-Masztafiak J; Lipiec E; Kayser Y; Kwiatek W; Wood B; Deacon GB; Berger G; Dufrasne F; Fernandes DL; Szlachetko J
    Drug Discov Today Technol; 2015 Sep; 16():1-6. PubMed ID: 26547415
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Curcumin and cancer: barriers to obtaining a health claim.
    Devassy JG; Nwachukwu ID; Jones PJ
    Nutr Rev; 2015 Mar; 73(3):155-65. PubMed ID: 26024538
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Potential photoactivated metallopharmaceuticals: from active molecules to supported drugs.
    Crespy D; Landfester K; Schubert US; Schiller A
    Chem Commun (Camb); 2010 Sep; 46(36):6651-62. PubMed ID: 20717579
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Biochemical pathways of copper complexes: progress over the past 5 years.
    Zehra S; Tabassum S; Arjmand F
    Drug Discov Today; 2021 Apr; 26(4):1086-1096. PubMed ID: 33486113
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Fluorescent metal-based complexes as cancer probes.
    de Almeida A; Bonsignore R
    Bioorg Med Chem Lett; 2020 Jul; 30(13):127219. PubMed ID: 32360103
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gold(i)-BODIPY-imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents.
    Trommenschlager A; Chotard F; Bertrand B; Amor S; Dondaine L; Picquet M; Richard P; Bettaïeb A; Le Gendre P; Paul C; Goze C; Bodio E
    Dalton Trans; 2017 Jun; 46(25):8051-8056. PubMed ID: 28594007
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Glycoconjugated Metal Complexes as Cancer Diagnostic and Therapeutic Agents.
    Bononi G; Iacopini D; Cicio G; Di Pietro S; Granchi C; Di Bussolo V; Minutolo F
    ChemMedChem; 2021 Jan; 16(1):30-64. PubMed ID: 32735702
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Five new diarylheptanoids from the rhizomes of Curcuma kwangsiensis and their antiproliferative activity.
    Chen SD; Gao JT; Liu JG; Liu B; Zhao RZ; Lu CJ
    Fitoterapia; 2015 Apr; 102():67-73. PubMed ID: 25704367
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Translational role of natural coumarins and their derivatives as anticancer agents.
    Menezes JC; Diederich M
    Future Med Chem; 2019 May; 11(9):1057-1082. PubMed ID: 31140865
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Organometallic compounds in cancer therapy: past lessons and future directions.
    Martins P; Marques M; Coito L; Pombeiro AJ; Baptista PV; Fernandes AR
    Anticancer Agents Med Chem; 2014; 14(9):1199-212. PubMed ID: 25173559
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Metal Drugs and the Anticancer Immune Response.
    Englinger B; Pirker C; Heffeter P; Terenzi A; Kowol CR; Keppler BK; Berger W
    Chem Rev; 2019 Jan; 119(2):1519-1624. PubMed ID: 30489072
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Synthesis, spectroscopic properties, molecular docking, anti-colon cancer and anti-microbial studies of some novel metal complexes for 2-amino-4-phenylthiazole derivative.
    Al-Harbi SA; Bashandy MS; Al-Saidi HM; Emara AAA; Mousa TAA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jun; 145():425-439. PubMed ID: 25796013
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Strategies for the Nuclear Delivery of Metal Complexes to Cancer Cells.
    Huynh M; Vinck R; Gibert B; Gasser G
    Adv Mater; 2024 Apr; 36(16):e2311437. PubMed ID: 38174785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.